Academic literature on the topic '336.7:794 (043.2)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '336.7:794 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "336.7:794 (043.2)"

1

Pranab, Ghosh, Debnath Utpal, and Prasad Pradhan Bhim. "Bromination of cholest-4-en-3,6-dione with N-bromosuccinimide in chloroform." Journal of Indian Chemical Society Vol. 90, Apr 2013 (2013): 533–37. https://doi.org/10.5281/zenodo.5771284.

Full text
Abstract:
Natural Product and Polymer Chemistry Laboratory, Department of Chemistry, University of North Bengal, Darjeeling-734 013, West Bengal, India <em>E-mail</em> : pizy12@yahoo.com <em>Manuscript received 15 December 2011, revised 20 March 2012, accepted 07 June 2012</em> The reaction of cholest-4-en-3,6-dione (1) with <em>N</em>-bromosuccinimide in chloroform furnishes four compounds which have been identified as 2,7&alpha;.-dibromo-cholest-1,4-dien-3,6-dione (2), 2,2,7&alpha;.-tribromo-cholest-4-en-3,6-dione (3), 2&alpha;., 7&alpha;.-dibromo-cholest-4-en-3,6-dione (4) and 2,2-dibromo-7-hydroxyl
APA, Harvard, Vancouver, ISO, and other styles
2

Semenova, Lioubov I., and Allan H. White. "Structural Systematics of Rare Earth Complexes. XIX (Hydrated) 1 : 2 Mononuclear Adducts of Lanthanoid(III) Chlorides with 2,2′-Bipyridine and 1,10-Phenanthroline." Australian Journal of Chemistry 52, no. 6 (1999): 571. http://dx.doi.org/10.1071/ch98052.

Full text
Abstract:
Room-temperature single-crystal X-ray structure determinations are recorded for a number of adducts of hydrated lanthanoid(III) trichlorides with 2,2′-bipyridine (‘bpy’) and 1,10-phenanthroline (‘phen’), crystallized from water, methanol or ethanol solutions, containing mononuclear arrays with 1 : 2 Ln/bpy or phen stoichiometry. LaCl3/phen/H2O(1 : 3 : 9), [(phen)2La(OH2)5]Cl3.phen.4H2O, although of overall 1 : 3 LaCl3/phen stoichiometry, has a lattice phen; it is orthorhombic, Pnna, a 19·947(7), b 16·457(5), c 12·213(2) Å, Z = 4; conventional R on |F| was 0·030 for No 2567 ‘observed’ (I &gt;3σ
APA, Harvard, Vancouver, ISO, and other styles
3

Pranab, Ghosh, Debnath Utpal, and P. Pradhan B. "Dehydrobromination and debromination of 2,2, 7a-tribromocholest-4-en-3,6-dione." Journal of Indian Chemical Society Vol. 89, Jun 2012 (2012): 837–39. https://doi.org/10.5281/zenodo.5763881.

Full text
Abstract:
Natural Product and Polymer Chemistry Laboratory, Department of Chemistry, University of North Bengal, Darjeeling-734 013, West Bengal, India <em>E-mail</em> : pizy12@yahoo.com Fax : 91-353-2699001 <em>Manuscript received 21 February 201J, revised 31 May 2011, accepted 17 October 2011</em> The reaction of 2,2, 7&alpha;-tribromocholest-4-en-3,6-dione (1) with lithium bromide in <em>N,N</em>-dimethyl formamide furnished a single compound identified as 2-bromocholest-1,4-dien-3,6-dione (2) by spectroscopic methods (UV, FT-IR, NMR and Mass).
APA, Harvard, Vancouver, ISO, and other styles
4

Demetri, George D., Jason J. Luke, Antoine Hollebecque, et al. "First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors." Journal of Clinical Oncology 37, no. 15_suppl (2019): 3004. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3004.

Full text
Abstract:
3004 Background: ABBV-085 is an ADC (conjugated to monomethyl auristatin E, drug:antibody ratio of 2:1) directed against leucine-rich repeat containing 15 (LRRC15), a type 1 transmembrane protein highly expressed on the surface of sarcomas and cancer-associated fibroblasts in stroma of many other cancers. ABBV-085 induced antitumor activity in both in vitro and xenograft models of sarcoma. This phase 1, first-in-human, 2-part study assessed the safety/tolerability of ABBV-085 in patients (pts) with advanced solid tumors (NCT02565758). Methods: Eligible pts (≥18 yr; advanced solid tumors) recei
APA, Harvard, Vancouver, ISO, and other styles
5

Bilen, Ozlem, Maha AAA Abd Elbasset, Jacquelyn Michele LaGrone, Imelda Tija, Lisa Bomgaars, and Jun Teruya. "Prothrombotic Markers As Predictors of Thrombosis in Newly Diagnosed Cancer Patients." Blood 118, no. 21 (2011): 2298. http://dx.doi.org/10.1182/blood.v118.21.2298.2298.

Full text
Abstract:
Abstract Abstract 2298 The prevalence of prothrombotic markers and their association with thrombosis in pediatric solid tumor patients is not well defined. This study was aimed to discern the value of the following laboratory measures in assessment of thrombotic risk in pediatric patients with solid tumor: Prothrombin and activated partial thromboplastin times (PT and aPTT), D-dimer level, fibrinogen level, inherited and acquired hypercoagulability risk factors and soluble pro-inflammatory cytokines. Forty pediatric patients with newly-diagnosed malignancy and same number of age and sex-matche
APA, Harvard, Vancouver, ISO, and other styles
6

Roh, Kyoung Ho, Yu Kyung Kim, Shin-Woo Kim, et al. "Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea." Canadian Journal of Infectious Diseases and Medical Microbiology 2021 (May 12, 2021): 1–9. http://dx.doi.org/10.1155/2021/6651045.

Full text
Abstract:
The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) was investigated. Study subjects (N = 342) were retrospectively enrolled after being confirmed as SARS-CoV-2 positive, and their nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and sputum specimens were restored for SARS-CoV-2 retesting and respiratory pathogen detection. The majority of the subjects (96.5%, N = 330) were confirmed as SARS-CoV-2 positive using NPS/OPS spe
APA, Harvard, Vancouver, ISO, and other styles
7

Gomes, Tiago Halyson de Oliveira, Welleson Feitosa Gazel, Emanuela Ferreira Goulart, Jennifer Lee Gonçalves, Gabriel Vargas Maia Chaves, and Lígia Luana Freire da Silva. "ÓBITOS DEVIDOS À SEPSE ESTREPTOCÓCICA NO BRASIL: ANÁLISE DE 13 ANOS." Revista ft 29, no. 143 (2025): 45–46. https://doi.org/10.69849/revistaft/ch10202502210945.

Full text
Abstract:
Introdução: A sepse é uma síndrome caracterizada por uma resposta inflamatória exacerbada a uma infecção, levando à disfunção orgânica e risco elevado de morte. Fatores de risco como o uso de cateteres, sonda uretral, imunossupressão, comorbidades, infecções pré-existentes, resistência antimicrobiana e estado nutricional comprometido são determinantes importantes para o desenvolvimento da doença. Objetivos: O objetivo do presente trabalho é realizar o levantamento epidemiológico acerca dos óbitos por casos de septicemia estreptocócica no Brasil, em um período de 13 anos. Bem como realizar o le
APA, Harvard, Vancouver, ISO, and other styles
8

Cannon, Joseph G. "Comprehensive Organic Functional Group Transformations Edited by A. R. Katritzky, O. Meth-Cohn, and C. W. Rees. Pergamon Press (Elsevier Science Ltd.), Tarrytown, NY. 1995. 7 vols., 19.5 × 28 cm. vol. 1, xix + 1420 pp; vol. 2, xix + 1441 pp; vol. 3, xix + 941 pp; vol. 4, xix + 1352 pp; vol. 5, xix + 1442 pp; vol. 6, xix + 933 pp; vol. 7, xvii + 1251 pp. ISBN 0-08-042-322-1; 0-08-042-323-X; 0-08-042-324-8; 0-08-0442-325-6; 0-08-042-326-4; 0-08-042-704-9; 0-08-042-705-7. $4310 (set)." Journal of Medicinal Chemistry 40, no. 12 (1997): 1940. http://dx.doi.org/10.1021/jm970186l.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Molina Collada, J., F. Sánchez-Alonso, C. Bohórquez, et al. "OP0138 RISK OF CANCER AFTER BIOLOGIC AND TARGETED SYNTHETIC DMARDS INITIATION IN PATIENTS WITH RHEUMATIC DISEASES AND A HISTORY OF PRIOR MALIGNANCY: DATA FROM THE BIOBADASER REGISTRY." Annals of the Rheumatic Diseases 81, Suppl 1 (2022): 88.2–89. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5030.

Full text
Abstract:
BackgroundPatients with a history of cancer are routinely excluded from randomized controlled trials. As consequence, data on the safety of biologic disease modifying antirheumatic drugs (bDMARDS) and targeted synthetic (ts) DMARDs are limited. Although real world data from various national registries have not provided evidence of increased cancer recurrence, additional data from real-world registries may help to confirm safety of non-TNFi bDMARDs and tsDMARDs regarding cancer recurrence to guide treatment decisions.ObjectivesTo compare the risk of incident malignancy with exposure to differen
APA, Harvard, Vancouver, ISO, and other styles
10

Kwon, Taesung, Stacy Kenyon, Kimberly Kilheeney, Stanley Martin, and Mark Shelly. "Prevalence of SARS-CoV-2 Antibody in Healthcare Workers in Central Pennsylvania." Antimicrobial Stewardship & Healthcare Epidemiology 1, S1 (2021): s49. http://dx.doi.org/10.1017/ash.2021.93.

Full text
Abstract:
Background: Determining the incidence of SARS-CoV-2 in healthcare workers (HCW) is important in assessing the safety of the work environment. Though of limited use in acute illness, serologic testing can detect some infections that occur undetected. We compared the prevalence of antibodies to SARS-CoV-2 to a place of work, exposure by role and department, and use of various prevention methods. Methods: Healthcare workers (HCWs) working in Geisinger Health System were offered voluntary serology through Employee Health. Before they had blood taken, they completed a brief questionnaire. Testing w
APA, Harvard, Vancouver, ISO, and other styles
More sources

Reports on the topic "336.7:794 (043.2)"

1

Newman-Toker, David E., Susan M. Peterson, Shervin Badihian, et al. Diagnostic Errors in the Emergency Department: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), 2022. http://dx.doi.org/10.23970/ahrqepccer258.

Full text
Abstract:
Objectives. Diagnostic errors are a known patient safety concern across all clinical settings, including the emergency department (ED). We conducted a systematic review to determine the most frequent diseases and clinical presentations associated with diagnostic errors (and resulting harms) in the ED, measure error and harm frequency, as well as assess causal factors. Methods. We searched PubMed®, Cumulative Index to Nursing and Allied Health Literature (CINAHL®), and Embase® from January 2000 through September 2021. We included research studies and targeted grey literature reporting diagnosti
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!